Botans 125 Tablet contains Bosentan 125 mg, an endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension (PAH). It helps relax blood vessels in the lungs, reduce pulmonary vascular resistance, and improve exercise capacity and quality of life in affected patients.
Belonging to the cardiology and pulmonary care segment, Bosentan is prescribed for patients with primary or secondary pulmonary hypertension, often under specialist supervision. Its efficacy ensures a strong prescription base in hospitals and specialty clinics.
Regular administration of Botans 125 Tablet can improve functional capacity, reduce symptoms like shortness of breath, and slow disease progression, making it a key therapy in PAH management.
For PCD pharma franchise partners, bulk distributors, exporters, and third-party manufacturing clients, Botans 125 Tablet represents a profitable B2B opportunity, with recurring demand across Indian hospitals, clinics, and pharmacy networks.